table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Rheumatoid Arthritis Devices
1.2 Key Market Segments
1.2.1 Rheumatoid Arthritis Devices Segment by Type
1.2.2 Rheumatoid Arthritis Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Rheumatoid Arthritis Devices Market Overview
2.1 Global Market Overview
2.1.1 Global Rheumatoid Arthritis Devices Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Rheumatoid Arthritis Devices Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Rheumatoid Arthritis Devices Market Competitive Landscape
3.1 Global Rheumatoid Arthritis Devices Sales by Manufacturers (2019-2024)
3.2 Global Rheumatoid Arthritis Devices Revenue Market Share by Manufacturers (2019-2024)
3.3 Rheumatoid Arthritis Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Rheumatoid Arthritis Devices Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Rheumatoid Arthritis Devices Sales Sites, Area Served, Product Type
3.6 Rheumatoid Arthritis Devices Market Competitive Situation and Trends
3.6.1 Rheumatoid Arthritis Devices Market Concentration Rate
3.6.2 Global 5 and 10 Largest Rheumatoid Arthritis Devices Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Rheumatoid Arthritis Devices Industry Chain Analysis
4.1 Rheumatoid Arthritis Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Rheumatoid Arthritis Devices Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Rheumatoid Arthritis Devices Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Rheumatoid Arthritis Devices Sales Market Share by Type (2019-2024)
6.3 Global Rheumatoid Arthritis Devices Market Size Market Share by Type (2019-2024)
6.4 Global Rheumatoid Arthritis Devices Price by Type (2019-2024)
7 Rheumatoid Arthritis Devices Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Rheumatoid Arthritis Devices Market Sales by Application (2019-2024)
7.3 Global Rheumatoid Arthritis Devices Market Size (M USD) by Application (2019-2024)
7.4 Global Rheumatoid Arthritis Devices Sales Growth Rate by Application (2019-2024)
8 Rheumatoid Arthritis Devices Market Segmentation by Region
8.1 Global Rheumatoid Arthritis Devices Sales by Region
8.1.1 Global Rheumatoid Arthritis Devices Sales by Region
8.1.2 Global Rheumatoid Arthritis Devices Sales Market Share by Region
8.2 North America
8.2.1 North America Rheumatoid Arthritis Devices Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Rheumatoid Arthritis Devices Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Rheumatoid Arthritis Devices Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Rheumatoid Arthritis Devices Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Rheumatoid Arthritis Devices Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Active Implants LLC
9.1.1 Active Implants LLC Rheumatoid Arthritis Devices Basic Information
9.1.2 Active Implants LLC Rheumatoid Arthritis Devices Product Overview
9.1.3 Active Implants LLC Rheumatoid Arthritis Devices Product Market Performance
9.1.4 Active Implants LLC Business Overview
9.1.5 Active Implants LLC Rheumatoid Arthritis Devices SWOT Analysis
9.1.6 Active Implants LLC Recent Developments
9.2 Anika Therapeutics, Inc.
9.2.1 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Basic Information
9.2.2 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Overview
9.2.3 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices Product Market Performance
9.2.4 Anika Therapeutics, Inc. Business Overview
9.2.5 Anika Therapeutics, Inc. Rheumatoid Arthritis Devices SWOT Analysis
9.2.6 Anika Therapeutics, Inc. Recent Developments
9.3 Arthrex, Inc.
9.3.1 Arthrex, Inc. Rheumatoid Arthritis Devices Basic Information
9.3.2 Arthrex, Inc. Rheumatoid Arthritis Devices Product Overview
9.3.3 Arthrex, Inc. Rheumatoid Arthritis Devices Product Market Performance
9.3.4 Arthrex, Inc. Rheumatoid Arthritis Devices SWOT Analysis
9.3.5 Arthrex, Inc. Business Overview
9.3.6 Arthrex, Inc. Recent Developments
9.4 Asahi Kasei Pharma Corporation
9.4.1 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Basic Information
9.4.2 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Overview
9.4.3 Asahi Kasei Pharma Corporation Rheumatoid Arthritis Devices Product Market Performance
9.4.4 Asahi Kasei Pharma Corporation Business Overview
9.4.5 Asahi Kasei Pharma Corporation Recent Developments
9.5 B. Braun Melsungen AG
9.5.1 B. Braun Melsungen AG Rheumatoid Arthritis Devices Basic Information
9.5.2 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Overview
9.5.3 B. Braun Melsungen AG Rheumatoid Arthritis Devices Product Market Performance
9.5.4 B. Braun Melsungen AG Business Overview
9.5.5 B. Braun Melsungen AG Recent Developments
9.6 CONMED Corporation
9.6.1 CONMED Corporation Rheumatoid Arthritis Devices Basic Information
9.6.2 CONMED Corporation Rheumatoid Arthritis Devices Product Overview
9.6.3 CONMED Corporation Rheumatoid Arthritis Devices Product Market Performance
9.6.4 CONMED Corporation Business Overview
9.6.5 CONMED Corporation Recent Developments
9.7 EMulate Therapeutics, Inc. (Nativis, Inc.)
9.7.1 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Basic Information
9.7.2 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Overview
9.7.3 EMulate Therapeutics, Inc. (Nativis, Inc.) Rheumatoid Arthritis Devices Product Market Performance
9.7.4 EMulate Therapeutics, Inc. (Nativis, Inc.) Business Overview
9.7.5 EMulate Therapeutics, Inc. (Nativis, Inc.) Recent Developments
9.8 Integra Lifesciences Corporation
9.8.1 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Basic Information
9.8.2 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Overview
9.8.3 Integra Lifesciences Corporation Rheumatoid Arthritis Devices Product Market Performance
9.8.4 Integra Lifesciences Corporation Business Overview
9.8.5 Integra Lifesciences Corporation Recent Developments
9.9 Johnson and Johnson (DePuy Synthes Inc.)
9.9.1 Johnson and Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Basic Information
9.9.2 Johnson and Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Overview
9.9.3 Johnson and Johnson (DePuy Synthes Inc.) Rheumatoid Arthritis Devices Product Market Performance
9.9.4 Johnson and Johnson (DePuy Synthes Inc.) Business Overview
9.9.5 Johnson and Johnson (DePuy Synthes Inc.) Recent Developments
9.10 Novartis AG
9.10.1 Novartis AG Rheumatoid Arthritis Devices Basic Information
9.10.2 Novartis AG Rheumatoid Arthritis Devices Product Overview
9.10.3 Novartis AG Rheumatoid Arthritis Devices Product Market Performance
9.10.4 Novartis AG Business Overview
9.10.5 Novartis AG Recent Developments
9.11 RTI Surgical, Inc.
9.11.1 RTI Surgical, Inc. Rheumatoid Arthritis Devices Basic Information
9.11.2 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Overview
9.11.3 RTI Surgical, Inc. Rheumatoid Arthritis Devices Product Market Performance
9.11.4 RTI Surgical, Inc. Business Overview
9.11.5 RTI Surgical, Inc. Recent Developments
9.12 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.)
9.12.1 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Basic Information
9.12.2 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Overview
9.12.3 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Rheumatoid Arthritis Devices Product Market Performance
9.12.4 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Business Overview
9.12.5 Samsung Bioepis Co., Ltd. (Samsung Biologics and Biogen Ltd.) Recent Developments
9.13 Setpoint Medical Corporation
9.13.1 Setpoint Medical Corporation Rheumatoid Arthritis Devices Basic Information
9.13.2 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Overview
9.13.3 Setpoint Medical Corporation Rheumatoid Arthritis Devices Product Market Performance
9.13.4 Setpoint Medical Corporation Business Overview
9.13.5 Setpoint Medical Corporation Recent Developments
9.14 Smith and Nephew plc (Osiris Therapeutics, Inc.)
9.14.1 Smith and Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Basic Information
9.14.2 Smith and Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Overview
9.14.3 Smith and Nephew plc (Osiris Therapeutics, Inc.) Rheumatoid Arthritis Devices Product Market Performance
9.14.4 Smith and Nephew plc (Osiris Therapeutics, Inc.) Business Overview
9.14.5 Smith and Nephew plc (Osiris Therapeutics, Inc.) Recent Developments
9.15 Stryker Corporation (OrthoSpace Ltd.)
9.15.1 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Basic Information
9.15.2 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Overview
9.15.3 Stryker Corporation (OrthoSpace Ltd.) Rheumatoid Arthritis Devices Product Market Performance
9.15.4 Stryker Corporation (OrthoSpace Ltd.) Business Overview
9.15.5 Stryker Corporation (OrthoSpace Ltd.) Recent Developments
9.16 UCB Pharma S.A.
9.16.1 UCB Pharma S.A. Rheumatoid Arthritis Devices Basic Information
9.16.2 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Overview
9.16.3 UCB Pharma S.A. Rheumatoid Arthritis Devices Product Market Performance
9.16.4 UCB Pharma S.A. Business Overview
9.16.5 UCB Pharma S.A. Recent Developments
9.17 Zimmer Biomet
9.17.1 Zimmer Biomet Rheumatoid Arthritis Devices Basic Information
9.17.2 Zimmer Biomet Rheumatoid Arthritis Devices Product Overview
9.17.3 Zimmer Biomet Rheumatoid Arthritis Devices Product Market Performance
9.17.4 Zimmer Biomet Business Overview
9.17.5 Zimmer Biomet Recent Developments
10 Rheumatoid Arthritis Devices Market Forecast by Region
10.1 Global Rheumatoid Arthritis Devices Market Size Forecast
10.2 Global Rheumatoid Arthritis Devices Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Rheumatoid Arthritis Devices Market Size Forecast by Country
10.2.3 Asia Pacific Rheumatoid Arthritis Devices Market Size Forecast by Region
10.2.4 South America Rheumatoid Arthritis Devices Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Rheumatoid Arthritis Devices by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Rheumatoid Arthritis Devices Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Rheumatoid Arthritis Devices by Type (2025-2030)
11.1.2 Global Rheumatoid Arthritis Devices Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Rheumatoid Arthritis Devices by Type (2025-2030)
11.2 Global Rheumatoid Arthritis Devices Market Forecast by Application (2025-2030)
11.2.1 Global Rheumatoid Arthritis Devices Sales (K Units) Forecast by Application
11.2.2 Global Rheumatoid Arthritis Devices Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
